Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)Jan Lewis Brandes, David Kudrow, Suzanne Klise et al.|Cephalalgia|2019Cited by 99
Abemaciclib for the treatment of brain metastases (BM) secondary to hormone receptor positive (HR+), HER2 negative breast cancer.Sara M. Tolaney, Carey K. Anders, Timothy M. Costigan et al.|Journal of Clinical Oncology|2017Cited by 53